MedPath

Comparison of Outcome of Injection Sclerotherapy Versus Rubber Band Ligation for Second Degree Hemorrhoids

Not Applicable
Active, not recruiting
Conditions
Hemorrhoid
Interventions
Drug: Injection Sclerotherapy
Device: Rubber Band Ligation
Registration Number
NCT07199673
Lead Sponsor
Gulab Devi Hospital
Brief Summary

Objective of this study is to compare the outcome of Injection Sclerotherapy versus Rubber Band Ligation for second degree hemorrhoids in terms of bleeding and efficacy.

Detailed Description

There is a difference in the outcome of Injection Sclerotherapy versus Rubber Band Ligation for second degree hemorrhoids in terms of bleeding and efficacy.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Adults aged between 18 and 75 who have been diagnosed with second-degree hemorrhoids
Exclusion Criteria
  • Patients with thrombosed hemorrhoids, and those with serious comorbid conditions such as heart, kidney, or liver diseases, coagulation disorders, or severe anemia.

    • Individuals who have received treatment for hemorrhoids in the past six months.
    • Pregnant women.
    • Patients unable to commit to necessary follow-up appointments.
    • Patients with a history or current presence of colorectal cancer or anal malignancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group ISTInjection Sclerotherapy5% phenol in almond oil
Group RBLRubber Band Ligationrubber band is applied at the base of each hemorrhoid using Barron's Gun and Elise's tissue forceps.
Primary Outcome Measures
NameTimeMethod
Early per rectal Bleeding24 hours

within 24 hours post-procedure

Secondary Outcome Measures
NameTimeMethod
Delayed Bleeding Per rectal24 hours to 14th post operative day

24 hours to 14th post-operative day

Trial Locations

Locations (1)

Gulab devi Hospital Lahore

🇵🇰

Lahore, Punjab Province, Pakistan

Gulab devi Hospital Lahore
🇵🇰Lahore, Punjab Province, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.